Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C13H10Cl3N3O4S |
| Molecular Weight | 410.66 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NS(=O)(=O)C1=C(O)C(NC(=O)NC2=CC=CC(Cl)=C2Cl)=CC=C1Cl
InChI
InChIKey=WTLRWOHEKQGKDS-UHFFFAOYSA-N
InChI=1S/C13H10Cl3N3O4S/c14-6-2-1-3-8(10(6)16)18-13(21)19-9-5-4-7(15)12(11(9)20)24(17,22)23/h1-5,20H,(H2,17,22,23)(H2,18,19,21)
| Molecular Formula | C13H10Cl3N3O4S |
| Molecular Weight | 410.66 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:23:02 GMT 2025
by
admin
on
Mon Mar 31 23:23:02 GMT 2025
|
| Record UNII |
5HLP8UVL8M
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
276702-15-9
Created by
admin on Mon Mar 31 23:23:02 GMT 2025 , Edited by admin on Mon Mar 31 23:23:02 GMT 2025
|
PRIMARY | |||
|
9887803
Created by
admin on Mon Mar 31 23:23:02 GMT 2025 , Edited by admin on Mon Mar 31 23:23:02 GMT 2025
|
PRIMARY | |||
|
5HLP8UVL8M
Created by
admin on Mon Mar 31 23:23:02 GMT 2025 , Edited by admin on Mon Mar 31 23:23:02 GMT 2025
|
PRIMARY | |||
|
SB-332235
Created by
admin on Mon Mar 31 23:23:02 GMT 2025 , Edited by admin on Mon Mar 31 23:23:02 GMT 2025
|
PRIMARY | Class: Small molecule; Mechanism of Action: Interleukin 8 receptor antagonist; Highest Development Phase: Discontinued for Chronic obstructive pulmonary disease and Psoriasis |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Description: SB-332235 is a potent and specific CXCR2 antagonist. SB-332235 effectively inhibited CS-induced neutrophilia in a dose-dependent manner. (last updated: 2/11/2016).
|
